Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 16, 2026
Why Is BlackBerry (BB) Stock Down -12.59% Today?

Why Is BlackBerry (BB) Stock Down -12.59% Today?

Key Takeaways

  • BlackBerry shares plunged 12.59% to $9.30 on Thursday, marking one of the steepest single-day declines of the year.
  • Aggressive profit-taking following a year-to-date rally of more than 186% is the primary driver behind the sell-off.
  • Valuation concerns are intensifying, with the stock trading at a price-to-earnings ratio above 100x and discounted cash flow models suggesting significant overvaluation.
  • Insider selling and convertible note dilution risk are adding pressure, with the CEO and other executives offloading shares and a conversion window now open on $300 million in convertible notes.
  • Analyst sentiment remains mixed, with a consensus Hold rating and an average price target of $8.92, well below where the stock traded before today's drop.
  • Traders are watching upcoming Q2 fiscal 2027 results, new QNX design wins, and physical AI partnership developments for signs of whether the growth narrative can catch up to the valuation.

Opening Summary

BB, the stock of BlackBerry Limited — the Canadian enterprise software and cybersecurity company that has reinvented itself around automotive operating systems, embedded software, and secure communications — tumbled 12.59% in Thursday's trading session. The shares closed the prior session at $10.64 and were last trading at $9.30, a decline of $1.34. The move lower was not triggered by any single negative corporate announcement. Instead, market participants pointed to a confluence of profit-taking, valuation anxiety, insider selling activity, and looming convertible note dilution as the forces driving the sharp pullback.

Profit-Taking After a Historic Rally

The most immediate explanation for today's decline is straightforward: after a breathtaking run, traders are locking in gains. BB stock had surged more than 186% year-to-date through the start of this week, fueled by a better-than-expected fiscal first-quarter 2027 earnings report released on June 25. That report showed revenue of $152.9 million — up 25.6% year-over-year and comfortably ahead of the $136.1 million consensus estimate — along with earnings per share of $0.04, a penny above expectations. Management also raised its full-year revenue guidance to a range of $594 million to $621 million.

The rally that followed was powerful, but it also stretched the stock far above its historical trading ranges. With the 50-day simple moving average sitting near $9.12 and the 200-day near $5.69, the shares had become significantly extended. When momentum stalled earlier this week — the stock had already fallen 3.4% on July 15 — the door opened for a more aggressive round of selling. Thursday's volume of approximately 4.8 million shares was well below the 20.2 million daily average, suggesting the move was driven more by a vacuum of buyers than by a wave of panic selling.

Valuation Concerns Come to the Forefront

Even after today's steep drop, BB trades at a price-to-earnings ratio above 100x, a level that dwarfs the North American software industry average of roughly 29x. Multiple independent valuation frameworks have flagged the stock as overvalued. A discounted cash flow analysis suggests the shares may be overvalued by approximately 33.7% relative to projected future cash flows. The GF Value metric, another widely followed intrinsic value estimate, places fair value at just $3.74 per share — implying the stock was trading at a premium of more than 180% before today's sell-off.

The bull case rests on the transformative potential of BlackBerry's QNX operating system, which is already embedded in more than 275 million vehicles and is increasingly positioned as a safety-critical software layer for physical AI applications — including autonomous mobile robots, humanoid robots, surgical systems, and industrial automation. Partnerships with NVDA and ARM have added credibility to that narrative. But with the stock having priced in a great deal of future success, any hint that the growth story may take longer to materialize is being met with swift repricing.

Insider Selling and Convertible Note Overhang

Two additional factors are weighing on investor sentiment. First, insider selling has been notable. CEO John Joseph Giamatteo sold 152,012 shares on July 9 at an average price of $11.35, a transaction worth approximately $1.73 million. Other executives, including the CFO and Chief People Officer, have also sold shares in recent weeks. In total, insiders have sold roughly $4 million worth of stock over the past three months with no reported open-market purchases. While some of these sales were related to tax obligations upon the vesting of restricted stock units, the aggregate activity has nonetheless raised eyebrows.

Second, BlackBerry disclosed in a June 25 SEC filing that its 3.00% senior convertible unsecured notes due February 15, 2029, became convertible by holders starting July 1, 2026, through September 30, 2026. The conversion trigger was met after the share price exceeded 130% of the conversion price for the required period. Full conversion of all outstanding notes could result in the issuance of approximately 51.5 million new common shares, representing roughly 8.8% of the shares outstanding. While the company has the option to settle conversions in cash, shares, or a combination, the potential dilution adds a layer of uncertainty that the market is now pricing in.

Market Context and Trading Activity

Thursday's sell-off in BB occurred against a backdrop of mixed broader market performance. The S&P 500 was little changed, while the tech-heavy Nasdaq Composite posted modest declines. The move in BlackBerry was idiosyncratic rather than sector-driven, though some weakness in software and high-beta technology names may have contributed to the negative tone. The stock sliced through its 50-day simple moving average of $9.12 intraday, a technical level that had provided support during the recent rally. A close below that threshold could invite additional selling from momentum-oriented traders and quantitative strategies.

Trending AI Robots

For investors seeking to navigate volatile market conditions with a data-driven approach, Tickeron offers a curated selection of AI-powered trading bots through its Trending AI Robots page. The platform hosts hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this dynamic, regularly updated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore approaches that range from short-term momentum plays to longer-term trend-following models. Whether you are looking to complement your own analysis or discover new systematic strategies, the Trending AI Robots section provides a window into which algorithms are currently delivering results.

What Comes Next for BB

The path forward for BB hinges on execution. The company's QNX business is showing genuine momentum, with revenue growth accelerating to 26% in the most recent quarter and a contracted backlog that has more than doubled since fiscal 2022 to $940 million. The physical AI narrative — spanning autonomous vehicles, robotics, and industrial automation — represents a large and growing addressable market. However, the stock's valuation implies that investors are already discounting years of successful execution.

Key events on the horizon include the next quarterly earnings report, where management will need to demonstrate that the QNX growth trajectory remains intact and that the cybersecurity and secure communications segments are contributing to the bottom line. Any new automotive design wins, expansions of the Nvidia partnership, or concrete customer announcements in the robotics space could help validate the premium multiple. Conversely, any slowdown in royalty revenue growth, delays in contract conversions, or further insider selling could reinforce the bear case that the stock got ahead of its fundamentals. With analyst price targets clustered between $8.00 and $13.00, the market is clearly divided on whether BlackBerry's transformation story deserves its current valuation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BB

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


BB's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for BB moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In of the 37 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on BB as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BB advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

BB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for BB turned negative on July 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

BB moved below its 50-day moving average on July 17, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BB crossed bearishly below the 50-day moving average on July 27, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BB entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.854) is normal, around the industry mean (23.996). P/E Ratio (87.800) is within average values for comparable stocks, (75.895). Projected Growth (PEG Ratio) (1.678) is also within normal values, averaging (1.870). BB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (9.009) is also within normal values, averaging (132.177).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Twilio (NYSE:TWLO), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 34.65B. The market cap for tickers in the group ranges from 48.8K to 3.71T. MSFT holds the highest valuation in this group at 3.71T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 5%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 21%. WETO experienced the highest price growth at 92%, while CSAI experienced the biggest fall at -97%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was -15% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 72
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 92
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
BB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of hardware and software solutions for mobile communications

Industry ComputerCommunications

Profile
Details
Industry
Packaged Software
Address
2200 University Avenue East
Phone
+1 519 888-7465
Employees
3181
Web
https://www.blackberry.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.